Categories: News

Virbac : Declaration of the number of shares and voting rights 09/2021

 

 

 

 

 

 

 

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS

 

 

 

Information on the total number of voting rights and of shares representing the share capital

(Article 223-16 of the General regulations of the French Financial Market Authority – Autorité

des Marchés Financiers)

 

 

 

 

Quotation place: Euronext Paris

Compartiment A

ISIN code: FR0000031577

 

Date Total number of shares representing the share capital Total number of voting rights
September, 30 2021 8 458 000 Gross total of voting rights : 12 765 619
Net total* of voting rights : 12 758 750

 

Net total* = total number of voting rights attached to the total number of shares net of shares with no voting rights.

 

 

 

 

 

 

 

VIRBAC: Shaping the future of animal health

NYSE Euronext – Compartiment A / Code ISIN: FR0000031577 / MNEMO: VIRP

Corporate Finance: tel. 33 4 92 08 71 32 / Email: finances@virbac.com

Website: www.virbac.com

Attachment

Staff

Recent Posts

Cosmo Pharmaceuticals Announces Strong Full Year 2024 Revenue and Cash and Provides Business and Pipeline Updates

Ad hoc announcement pursuant to Art. 53 LR Revenue Growth: Full-year 2024 revenue of €265.7…

4 hours ago

RiDYMO® Designs Cyclic Peptide for “Undruggable” β-Catenin Target Within Two Months

BEIJING, Jan. 8, 2025 /PRNewswire/ -- In a recent achievement, DP Technology's hit discovery platform RiDYMO® has…

6 hours ago

ITRI Opens CES 2025 With Trend-Leading Showcase and Partnership With Reliance Biotech Corporation

LAS VEGAS, Jan. 8, 2025 /PRNewswire/ -- The Industrial Technology Research Institute (ITRI) initiated its presence…

6 hours ago

NOTICE OF DATA BREACH

LOS ANGELES, Jan. 8, 2025 /PRNewswire/ -- Dear members of the STIIIZY community:  Stiiizy, Inc.…

6 hours ago

Ascent Strategy Group Recognized by Modern Healthcare’s Best in Business, Affirms Health Equity Mission Amid Alarming Disparities

Agency Founder nominated Outstanding Agency Professional, Innovator of the Year First public relations agency built…

6 hours ago

Onco-Innovations Provides Information Regarding Exclusive License for Patented Drug with Potential to Enhance Cancer Treatment Options

VANCOUVER, BC / ACCESSWIRE / January 8, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or…

9 hours ago